Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01121588
Brief Title: An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

First Submitted : May 10, 2010
First Submitted that Met QC Criteria : May 10, 2010
First Posted : May 12, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : November 16, 2020
Last Update Posted : November 17, 2020